Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-incisional antibiotics for prevention of wound infection after skin cancer excision
ACTRN12616000364471Phase 4Completed
- Sponsor
- A/Prof (Hon) Jon Mathy
- Start
- Feb 2019
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of flucloxacillin, clindamycin, lidocaine, epinephrine and sodium bicarbonate in surgical site infection (SSI) and Graft failure (3 arms), sponsored by A/Prof (Hon) Jon Mathy. Primary endpoint: Wound infection. Started Feb 2019; status: completed.
02
Drugs
flucloxacillinclindamycinlidocaineepinephrinesodium bicarbonate
03
Conditions
surgical site infection (SSI)Graft failure
Beyond the preview
Go deeper on ACTRN12616000364471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616000364471.